Lindqvist B, Andersen S, Isacsson B, Lundberg E
Medical Department, Umeå University, Sweden.
Int Urol Nephrol. 1989;21(5):555-9. doi: 10.1007/BF02549595.
The course of uraemia in 47 patients with renal amyloidosis has been studied. The median survival with a S-creatinine of 150 mumol/l was approximately 18 months, but 15% survived for more than 3 years. Deterioration arose often suddenly and was of unclear cause. Approximately 25% of the patients improved for a while and the reason for this temporary improvement is also unclear. The unsteady course during the uraemia period for amyloidosis patients makes prognosis calculations very much less accurate than for patients with cystic kidneys.
对47例肾淀粉样变性患者的尿毒症病程进行了研究。血清肌酐为150μmol/L时的中位生存期约为18个月,但15%的患者存活超过3年。病情恶化常常突然出现且原因不明。约25%的患者有一段时间病情有所改善,这种暂时改善的原因也不清楚。淀粉样变性患者在尿毒症期的病程不稳定,使得预后计算比多囊肾患者的预后计算准确性低得多。